Event: Alphalife Sciences Highlights GenAI-Driven Automation in Clinical Trials at 2024 SAPA-DC Annual Conference
Oct 21, 2024At the 2024 SAPA-DC Annual Conference, AlphaLife Sciences CEO Sharon Chen highlighted AuroraPrime, a GenAI-powered platform that automates clinical trial processes. Tools like AuroraPrime Create and AuroraPrime Comprehend streamline document drafting and data monitoring, driving innovation in clinical research through GenAI and strategic partnerships.
At the 2024 SAPA-DC Annual Conference, Sharon Chen, CEO and founder of AlphaLife Sciences, delivered a compelling keynote on “GenAI-Enabled eClinical Solutions.” Held on October 12th, the event, themed "The Next Generation of Medicine," brought together leaders from the pharmaceutical, biotech, and regulatory sectors.
Organized by the United States Chinese Pharmaceutical Association (SAPA-DC), the conference showcased the Greater Washington DC/Baltimore area's prominent role as a biotech hub, home to over 300 life sciences companies.
Sharon Chen’s keynote highlighted the transformative role of GenAI in drug development, particularly focusing on AlphaLife Sciences’ flagship platform, AuroraPrime. This GenAI-powered platform is designed to enhance clinical trials by streamlining medical writing and data monitoring.
AuroraPrime Create, a core component, accelerates the drafting of key clinical documents such as Clinical Study Reports (CSRs) through automation and GenAI-powered features, improving both speed and quality. The platform's AuroraPrime Create for Microsoft Word automates time-consuming tasks like incorporating and updating TFLs, making drug development more efficient and compliant with regulatory standards.
AuroraPrime Comprehend, another vital tool, enhances clinical trial data monitoring through real-time insights and automation, improving decision-making and operational efficiency.
Backed by strategic partnerships with Microsoft, Google, and Johnson and Johnson Innovation JLABS, AlphaLife Sciences is at the forefront of GenAI-driven solutions, helping to shape the future of clinical research and healthcare.
